169 related articles for article (PubMed ID: 22959125)
1. Balancing the risks and benefits for pioglitazone in type 2 diabetes.
Johnson JA; Colmers IN
Diabetes Res Clin Pract; 2012 Oct; 98(1):1-2. PubMed ID: 22959125
[No Abstract] [Full Text] [Related]
2. Pioglitazone and the risk of bladder cancer.
Hillaire-Buys D; Faillie JL
BMJ; 2012 May; 344():e3500. PubMed ID: 22653979
[No Abstract] [Full Text] [Related]
3. Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.
Zhu Z; Shen Z; Lu Y; Zhong S; Xu C
Diabetes Res Clin Pract; 2012 Oct; 98(1):159-63. PubMed ID: 22705039
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone Use and Risk of Bladder Cancer.
Davies BJ
JAMA; 2015 Dec; 314(23):2568. PubMed ID: 26670977
[No Abstract] [Full Text] [Related]
5. Pioglitazone Use and Risk of Bladder Cancer.
Singh S; Suchard MA
JAMA; 2015 Dec; 314(23):2567-8. PubMed ID: 26670976
[No Abstract] [Full Text] [Related]
6. No strong association is found between pioglitazone and bladder cancer.
Wise J
BMJ; 2015 Jul; 351():h3934. PubMed ID: 26202496
[No Abstract] [Full Text] [Related]
7. Pioglitazone Use and Risk of Bladder Cancer--Reply.
Ferrara A; Lewis JD; Habel LA
JAMA; 2015 Dec; 314(23):2568-9. PubMed ID: 26670978
[No Abstract] [Full Text] [Related]
8. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
Fujimoto K; Hamamoto Y; Honjo S; Kawasaki Y; Mori K; Tatsuoka H; Matsuoka A; Wada Y; Ikeda H; Fujikawa J; Koshiyama H
Diabetes Res Clin Pract; 2013 Feb; 99(2):e21-3. PubMed ID: 23228390
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone--when is a prescription drug safe?
Loke YK; Mattishent K
Nat Rev Urol; 2015 Dec; 12(12):655-6. PubMed ID: 26416647
[No Abstract] [Full Text] [Related]
10. Eight cases of bladder cancer in pioglitazone users from India.
Unnikrishnan R; Sundramoorthy C; Deshpande N; Sarvothaman R; Sahay RK; Mehtalia S; Venkatraman JV; Mohan V
J Assoc Physicians India; 2012 Dec; 60():66. PubMed ID: 23781679
[No Abstract] [Full Text] [Related]
11. Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
Aschenbrenner DS
Am J Nurs; 2017 Apr; 117(4):25. PubMed ID: 28333739
[No Abstract] [Full Text] [Related]
12. Pioglitazone: European approval maintained despite the acknowledged risks.
Prescrire Int; 2012 Jul; 21(129):181. PubMed ID: 22852286
[No Abstract] [Full Text] [Related]
13. Meta-analysis confirms raised risk of bladder cancer from pioglitazone.
Kermode-Scott B
BMJ; 2012 Jul; 345():e4541. PubMed ID: 22763399
[No Abstract] [Full Text] [Related]
14. Pioglitazone and risk of bladder cancer: clarification of the design of the French study.
Perez AT
Diabetologia; 2013 Jan; 56(1):227. PubMed ID: 23135221
[No Abstract] [Full Text] [Related]
15. Pioglitazone and bladder cancer: the pros and cons.
Panikar V
J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
[No Abstract] [Full Text] [Related]
16. Pioglitazone and risk of bladder cancer: clarification of the design of the French study. Reply to Perez AT [letter].
Neumann A; Weill A; Ricordeau P; Fagot JP; Alla F; Allemand H
Diabetologia; 2013 Jan; 56(1):228-9. PubMed ID: 23143195
[No Abstract] [Full Text] [Related]
17. Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!
Hillaire-Buys D; Faillie JL; Montastruc JL; Petit P
Eur J Clin Pharmacol; 2012 Dec; 68(12):1681-3. PubMed ID: 22576730
[No Abstract] [Full Text] [Related]
18. Pioglitazone for diabetes prevention.
Goldstein MR; Mascitelli L
N Engl J Med; 2011 Jul; 365(2):183; author reply 183-4. PubMed ID: 21751925
[No Abstract] [Full Text] [Related]
19. The Safety of Prescription Drugs.
Sharfstein JM; Kesselheim AS
JAMA; 2015 Jul; 314(3):233-4. PubMed ID: 26197182
[No Abstract] [Full Text] [Related]
20. The cage in search of a bird.
Kalra S
J Assoc Physicians India; 2012 Jan; 60():74-5. PubMed ID: 22715551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
